Catalent | CTLT - Gastos De Venta Y Administración



Gastos De Venta Y Administración Cambio Fecha
Agilent USD 476M 48M 2025-12
AstraZeneca USD 4.61B 4.46B 2025-12
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Bruker USD 247.2M 4.7M 2025-12
Centene USD 3.37B 236M 2025-12
Charles River Laboratories USD 196.14M 18.55M 2025-12
Cigna USD 3.19B 242M 2025-09
Danaher USD 2.03B 35M 2025-12
Dentsply International USD 383M 28M 2025-12
Elevance Health USD 10.91B 309M 2025-12
Eli Lilly USD 3.13B 391.3M 2025-12
Glaxosmithkline GBP 3.56B 650.29M 2025-12
Hologic USD 2.5B 2.24B 2025-12
Humana USD 3.36B 614M 2025-03
Illumina USD 283M 27M 2025-12
Intuitive Surgical USD 687.1M 113.8M 2025-12
IQVIA Holdings USD 468M 46M 2025-12
J&J USD 6.75B 831M 2025-12
Laboratory Of America USD 538.6M 13.8M 2025-12
McKesson USD 2.03B 44M 2025-12
Merck EUR 1.6B 136M 2025-12
Merck USD 2.85B 215M 2025-12
Mettler Toledo International USD 259.83M 11.43M 2025-12
Novartis USD 3.44B 128M 2025-12
Pfizer USD 4.08B 894M 2025-12
Quest Diagnostics USD 504M 3M 2025-12
Repligen USD 74.36M 703K 2025-12
Revvity USD 251.73M 9.82M 2025-12
Roche Holding CHF 7.28B 3.99B 2025-12
Supernus Pharmaceuticals USD 122.39M 57.29M 2025-12
Thermo Fisher Scientific USD 1.98B 182M 2025-12
UnitedHealth USD 15.22B 1.44B 2025-09
Veradigm USD 27.28M 5.24M 2022-12
Waters USD 240.01M 25.78M 2025-12
West Pharmaceutical Services USD 106.5M 3.8M 2025-12